Literature DB >> 27486278

Gonadotropin Alone is a Better Drug for Ovarian Stimulation than in Combination with Clomiphene in Intrauterine Insemination.

Sushma Sinha1, Neha Agrawal2.   

Abstract

OBJECTIVE: This study compares the efficacy of sequential clomiphene citrate (CC) + Gonadotropin to that of Gonadotropin alone with ultrasound monitoring.
METHODS: It is a retrospective analytic study done on a total of 100 couples to compare two groups receiving CC + Gonadotropin and Gonadotropin alone for ovarian stimulation followed by intrauterine Insemination (IUI). We studied the cycle performance parameters. Cumulative pregnancy rates and ovulation rates were the primary outcomes. Results were analyzed following the intention-to-treat principle.
RESULTS: There were no significant differences with respect to indications and the numbers of dominant follicles recruited. The endometrial thickness was significantly better in Gonadotropin-alone group (P < 0.05). Ovulation rate was better for CC + Gonadotropin at 95.91 %. Nine pregnancies were in the CC + Gonadotropin group (18.36 %) and 17 in Gonadotropin-alone group (33.3 %).
CONCLUSIONS: Significant differences in pregnancy rates and endometrial thickness were seen. Gonadotropin alone thus appears to give better results, but CC + Gonadotropin seems to be a cost-effective drug.

Entities:  

Keywords:  Clomiphene citrate; Gonadotropin; Intrauterine insemination; Sub fertility

Year:  2015        PMID: 27486278      PMCID: PMC4958069          DOI: 10.1007/s13224-015-0686-9

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  12 in total

Review 1.  Controlled ovarian hyperstimulation and intrauterine insemination for treatment of infertility.

Authors:  W C Dodson; A F Haney
Journal:  Fertil Steril       Date:  1991-03       Impact factor: 7.329

Review 2.  Ovarian stimulation protocols (anti-oestrogens, gonadotrophins with and without GnRH agonists/antagonists) for intrauterine insemination (IUI) in women with subfertility.

Authors:  A E P Cantineau; B J Cohlen; M J Heineman
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18

3.  [Ovulation induction increases pregnancy rate during intrauterine insemination compared with natural cycles].

Authors:  R Streda; J Stepán; I Zadrobílková; E Cermáková
Journal:  Ceska Gynekol       Date:  2007-12

Review 4.  The influence of the number of follicles on pregnancy rates in intrauterine insemination with ovarian stimulation: a meta-analysis.

Authors:  M M E van Rumste; I M Custers; F van der Veen; M van Wely; J L H Evers; B W J Mol
Journal:  Hum Reprod Update       Date:  2008-08-06       Impact factor: 15.610

Review 5.  Use of exogenous gonadotropins in anovulatory women: a technical bulletin.

Authors: 
Journal:  Fertil Steril       Date:  2008-11       Impact factor: 7.329

6.  Endometrial thickness and pregnancy outcome after intrauterine insemination.

Authors:  Seddigheh Esmailzadeh; Mahbobeh Faramarzi
Journal:  Fertil Steril       Date:  2007-04-16       Impact factor: 7.329

7.  Menotropins alone are superior to a clomiphene citrate and menotropin combination for superovulation induction among clomiphene citrate failures.

Authors:  M X Ransom; N C Doughman; A J Garcia
Journal:  Fertil Steril       Date:  1996-06       Impact factor: 7.329

8.  Comparison of letrozole with continuous gonadotropins and clomiphene-gonadotropin combination for ovulation induction in 1387 PCOS women after clomiphene citrate failure: a randomized prospective clinical trial.

Authors:  Ashalatha Ganesh; Sourendra Kant Goswami; Ratna Chattopadhyay; Koel Chaudhury; Baidyanath Chakravarty
Journal:  J Assist Reprod Genet       Date:  2009-01-07       Impact factor: 3.412

9.  Consensus on infertility treatment related to polycystic ovary syndrome.

Authors: 
Journal:  Hum Reprod       Date:  2008-03       Impact factor: 6.918

10.  Sequential clomiphene citrate/hMG versus hMG for ovulation induction in clomiphene citrate-resistant women.

Authors:  Ibrahim A Abdelazim; Hanan H Makhlouf
Journal:  Arch Gynecol Obstet       Date:  2012-10-19       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.